STOCK TITAN

Danaher Corporation (DHR) Financials

DHR
Trailing 12 months to June 26, 2026
Revenue $25.1B +4.6% YoY
Net Income $4.0B +17.3% YoY
EPS (Diluted) $5.63 +19.8% YoY
Free Cash Flow $5.5B +12.4% YoY
Market Cap $140.7B as of Sep 11, 2026
Price / Sales 5.6x on $25.1B revenue, trailing 12 months to June 26, 2026
Price / Earnings 35.1x on $4.0B net income, trailing 12 months to June 26, 2026
Price / Book 2.7x on $52.6B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 26, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 21, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DHR SEC filings page.

Danaher Corporation (DHR) reported $25.1B in revenue over the twelve months to Jun 26, 2026, up 4.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DHR FY2025

Danaher’s dominant mechanic is revenue recovery without profit recovery, as overhead growth keeps compressing operating conversion.

Operating cash flow was $6.4B versus net income of $3.6B in FY2025, showing that reported earnings understated cash generation. After $1.2B of capital expenditures, free cash flow remained $5.3B; cash conversion is being supported by noncash expense and reinvestment below depreciation rather than by rising earnings.

Revenue in FY2025 was $24.6B, close to FY2022’s $26.6B, yet the recovery has not restored prior profitability. Operating margin fell from 28.3% to 19.1% over that span, indicating that costs absorbed much of the regained scale.

Gross margin held at 59.1% in FY2025 versus 59.5% in FY2024, so production economics changed little. SG&A reached $8.2B as revenue recovered, placing the main pressure below gross profit; debt-to-equity also rose from 0.3x to 0.4x, indicating a modestly more leveraged posture.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 60 / 100
Financial Health Score 60/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Danaher Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
85

Danaher Corporation has an operating margin of 19.1%, meaning the company retains $19 of operating profit per $100 of revenue. This strong profitability earns a score of 85/100, reflecting efficient cost management and pricing power. This is down from 20.4% the prior year.

Growth
35

Danaher Corporation's revenue grew a modest 2.9% year-over-year to $24.6B. This slow but positive growth earns a score of 35/100.

Leverage
33

Danaher Corporation has a moderate D/E ratio of 0.35. This balance of debt and equity financing earns a leverage score of 33/100.

Liquidity
55

Danaher Corporation's current ratio of 1.87 indicates adequate short-term liquidity, earning a score of 55/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
88

Danaher Corporation converts 21.4% of revenue into free cash flow ($5.3B). This strong cash generation earns a score of 88/100.

Returns
62

Danaher Corporation's ROE of 6.9% shows moderate profitability relative to equity, earning a score of 62/100. This is down from 7.9% the prior year.

Altman Z-Score Safe
4.08

Danaher Corporation scores 4.08, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($140.7B) relative to total liabilities ($30.9B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Danaher Corporation passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.78x

For every $1 of reported earnings, Danaher Corporation generates $1.78 in operating cash flow ($6.4B OCF vs $3.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
17.70x

Danaher Corporation earns $17.70 in operating income for every $1 of interest expense ($4.7B vs $265.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.3B
YoY+5.5%
QoQ+5.3%
5Y CAGR+1.3%
10Y CAGR+7.0%

Danaher Corporation generated $6.3B in revenue in Q2 2026. This represents an increase of 5.5% from the same quarter a year earlier. Against the prior quarter it is up 5.3%.

EBITDA
$1.8B
YoY+30.3%
QoQ-9.4%

Danaher Corporation's EBITDA was $1.8B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 30.3% from the same quarter a year earlier. Against the prior quarter it is down 9.4%.

Net Income
$870.0M
YoY+56.8%
QoQ-15.5%
5Y CAGR-0.3%
10Y CAGR+4.3%

Danaher Corporation reported $870.0M in net income in Q2 2026. This represents an increase of 56.8% from the same quarter a year earlier. Against the prior quarter it is down 15.5%.

EPS (Diluted)
$1.23
YoY+59.7%
QoQ-15.2%
5Y CAGR+1.2%
10Y CAGR+4.5%

Danaher Corporation earned $1.23 per diluted share (EPS) in Q2 2026. This represents an increase of 59.7% from the same quarter a year earlier. Against the prior quarter it is down 15.2%.

Cash & Balance Sheet

Free Cash Flow
$1.3B
YoY+16.1%
QoQ+16.6%
5Y CAGR-3.8%
10Y CAGR+12.0%

Danaher Corporation generated $1.3B in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 16.1% from the same quarter a year earlier. Against the prior quarter it is up 16.6%.

Cash & Debt
$4.3B
YoY+47.0%
QoQ-23.7%
5Y CAGR-5.2%
10Y CAGR+5.6%

Danaher Corporation held $4.3B in cash against $25.1B in long-term debt as of Q2 2026.

Shares Outstanding
703M
YoY-1.8%
QoQ-0.7%
5Y CAGR-0.2%
10Y CAGR-0.1%

Danaher Corporation had 703M shares outstanding in Q2 2026. This represents a decrease of 1.8% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin
57.6%
YoY-1.7pp
QoQ-2.7pp
5Y change+2.8pp
10Y change+3.1pp

Danaher Corporation's gross margin was 57.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.7 percentage points.

Operating Margin
18.0%
YoY+5.2pp
QoQ-4.6pp
5Y change-0.5pp
10Y change+4.0pp

Danaher Corporation's operating margin was 18.0% in Q2 2026, reflecting core business profitability. This is up 5.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.6 percentage points.

Net Margin
13.9%
YoY+4.5pp
QoQ-3.4pp
5Y change-1.1pp
10Y change-4.0pp

Danaher Corporation's net profit margin was 13.9% in Q2 2026, showing the share of revenue converted to profit. This is up 4.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.4 percentage points.

Return on Equity
1.7%
YoY+0.6pp
QoQ-0.3pp
5Y change-0.7pp
10Y change-0.8pp

Danaher Corporation's ROE was 1.7% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.

Capital Allocation

R&D Spending
$412.0M
YoY+2.2%
QoQ+6.5%

Danaher Corporation invested $412.0M in research and development in Q2 2026. This represents an increase of 2.2% from the same quarter a year earlier. Against the prior quarter it is up 6.5%.

Share Buybacks
$894.0M

Danaher Corporation spent $894.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures
$269.0M
YoY+8.5%
QoQ+13.5%
5Y CAGR+7.5%
10Y CAGR+8.7%

Danaher Corporation invested $269.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 8.5% from the same quarter a year earlier. Against the prior quarter it is up 13.5%.

DHR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DHR quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$6.3B+5.5%$6.0B+3.7%$6.8B+4.6%$6.1B+4.4%$5.9B+3.4%$5.7B-0.9%$6.5B+2.1%$5.8B+3.1%
Cost of Revenue$2.7B+10.0%$2.4B+5.8%$2.9B+8.5%$2.5B+5.5%$2.4B+4.2%$2.2B-3.4%$2.6B$2.4B+2.0%
Gross Profit$3.6B+2.5%$3.6B+2.3%$4.0B+2.0%$3.5B+3.6%$3.5B+2.8%$3.5B+0.7%$3.9B+2.9%$3.4B+3.8%
R&D Expenses$412.0M+2.2%$387.0M+2.1%$438.0M-0.9%$378.0M-1.3%$403.0M+3.1%$379.0M+3.0%$442.0M$383.0M+5.8%
SG&A Expenses$2.1B-12.2%$1.9B+0.1%$2.0B+0.1%$2.0B-3.3%$2.4B+26.3%$1.9B+2.8%$2.0B$2.1B+19.2%
Operating Income$1.1B+48.3%$1.3B+5.5%$1.5B+5.4%$1.2B+20.5%$760.0M-34.9%$1.3B-2.9%$1.4B+6.6%$958.0M-19.2%
EBITDA$1.8B+30.3%$2.0B+5.7%$2.1B+5.2%$1.8B+14.7%$1.4B-21.6%$1.9B-1.7%$2.0B$1.5B-9.8%
Interest Expense$107.0M+50.7%$63.0M-12.5%$55.0M-9.8%$67.0M-23.0%$71.0M+9.2%$72.0M+10.8%$61.0M$87.0M+19.2%
Income Tax$208.0M+108.0%$206.0M+17.7%$190.0M-17.0%$168.0M+5.7%$100.0M-43.2%$175.0M-4.4%$229.0M$159.0M-23.2%
Net Income$870.0M+56.8%$1.0B+7.9%$1.2B+10.2%$908.0M+11.0%$555.0M-38.8%$954.0M-12.3%$1.1B+0.6%$818.0M-27.5%
EPS (Basic)$1.23+59.7%$1.45+9.0%$1.69+12.7%$1.28+13.3%$0.77-37.4%$1.33-9.5%$1.50+2.7%$1.13-26.1%
EPS (Diluted)$1.23+59.7%$1.45+9.8%$1.68+12.8%$1.27+13.4%$0.77-36.9%$1.32-9.0%$1.49+2.8%$1.12-25.8%
Diluted Shares (Avg)708M-1.6%711M-1.3%N/A714M-2.2%719M-3.1%721M-3.7%N/A729M-2.2%

DHR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DHR quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$92.4B+13.2%$83.5B+5.6%$83.5B+7.6%$79.9B-0.9%$81.6B+3.9%$79.1B-5.1%$77.5B-8.2%$80.6B-8.1%
Current Assets$13.4B+21.7%$13.9B+46.3%$12.8B+34.3%$9.6B-4.5%$11.0B+14.5%$9.5B-33.7%$9.5B-31.9%$10.1B-52.6%
Cash & Equivalents$4.3B+47.0%$5.7B+186.1%$4.6B+122.1%$1.5B-41.8%$3.0B+24.6%$2.0B-71.7%$2.1B-64.6%$2.6B-78.6%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$3.3B+21.2%$2.6B+3.0%$2.5B+6.8%$2.7B-0.1%$2.7B+0.7%$2.5B-4.3%$2.3B-10.2%$2.7B-11.4%
Accounts Receivable$4.0B+11.3%$3.8B+8.9%$3.9B+10.6%$3.8B+7.1%$3.6B+8.1%$3.5B+3.8%$3.5B-9.8%$3.5B-16.5%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$47.4B+10.3%$42.8B+2.7%$43.2B+6.6%$42.9B+1.8%$43.0B+5.4%$41.7B+2.0%$40.5B-2.7%$42.2B+7.7%
Total Liabilities$39.8B+35.9%$30.6B+8.2%$30.9B+10.5%$28.8B-1.7%$29.3B+2.2%$28.3B-5.7%$28.0B-9.7%$29.3B-17.0%
Current Liabilities$8.1B+19.3%$7.5B+12.3%$6.8B+0.1%$6.3B-13.8%$6.8B+1.4%$6.6B-14.6%$6.8B-17.8%$7.3B-21.7%
Non-Current Liabilities$31.7B+40.8%$23.1B+7.0%$24.1B+13.8%$22.5B+2.4%$22.5B+2.4%$21.6B-2.5%$21.2B-6.7%$22.0B-15.3%
Long-Term Debt$25.1B+49.2%$17.6B+9.9%$18.4B+18.8%$16.8B+3.1%$16.9B+3.3%$16.0B-2.7%$15.5B-7.2%$16.3B-16.3%
Total Equity$52.6B+0.5%$52.9B+4.1%$52.5B+6.0%$51.1B-0.4%$52.3B+4.9%$50.8B-4.9%$49.5B-7.4%$51.3B-2.1%
Retained Earnings$48.2B+6.6%$47.6B+6.1%$46.9B+6.1%$45.9B+6.1%$45.2B+6.0%$44.9B+7.0%$44.2B+7.6%$43.3B+2.4%

DHR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DHR quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$1.5B+14.6%$1.3B+1.8%$2.1B+4.9%$1.7B+9.8%$1.3B-5.6%$1.3B-25.3%$2.0B+24.7%$1.5B-9.5%
Depreciation & Amortization$659.0M+7.9%$627.0M+6.1%$623.0M+4.7%$622.0M+5.2%$611.0M+5.3%$591.0M+0.9%$595.0M$591.0M+10.9%
Stock-Based Compensation$93.0M+2.2%$58.0M-4.9%N/A$83.0M-1.2%$91.0M+4.6%$61.0M+1.7%N/A$84.0M+6.3%
Capital Expenditures$269.0M+8.5%$237.0M-3.3%$371.0M-28.1%$292.0M-2.0%$248.0M-13.6%$245.0M-15.8%$516.0M+18.9%$298.0M-15.8%
Free Cash Flow$1.3B+16.1%$1.1B+2.9%$1.7B+16.2%$1.4B+12.8%$1.1B-3.5%$1.1B-27.2%$1.5B+26.8%$1.2B-7.8%
Investing Cash Flow-$10.1B-3832.9%-$249.0M-2.9%-$384.0M+44.7%-$312.0M+48.5%-$258.0M+28.3%-$242.0M+24.6%-$694.0M+88.5%-$606.0M-84.2%
Financing Cash Flow$7.3B+3044.5%$46.0M+103.7%$1.3B+178.1%-$2.8B-229.1%-$247.0M+95.7%-$1.3B-843.6%-$1.7B+24.7%-$845.0M-134.6%
Dividends Paid$283.0M+23.6%$226.0M+16.5%$226.0M+15.9%$229.0M+16.8%$229.0M+14.5%$194.0M+9.6%$195.0M-2.5%$196.0M-1.5%
Share Buybacks$894.0M$0-100.0%$0-100.0%$2.0B+214.1%$0-100.0%$1.1B$809.0M$640.0M

DHR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DHR quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin57.6%-1.7pp60.3%-0.8pp58.0%-1.5pp58.2%-0.5pp59.4%-0.3pp61.2%+1.0pp59.5%+0.5pp58.7%+0.4pp
Operating Margin18.0%+5.2pp22.6%+0.4pp22.0%+0.2pp19.1%+2.5pp12.8%-7.5pp22.2%-0.5pp21.8%+0.9pp16.5%-4.5pp
Net Margin13.9%+4.5pp17.3%+0.7pp17.5%+0.9pp15.0%+0.9pp9.3%-6.4pp16.6%-2.2pp16.6%-0.2pp14.1%-6.0pp
Return on Equity1.7%+0.6pp1.9%+0.1pp2.3%+0.1pp1.8%+0.2pp1.1%-0.8pp1.9%-0.2pp2.2%+0.2pp1.6%-0.6pp
Return on Assets0.9%+0.3pp1.2%0.0pp1.4%0.0pp1.1%+0.1pp0.7%-0.5pp1.2%-0.1pp1.4%+0.1pp1.0%-0.3pp
Current Ratio1.650.0x1.87+0.4x1.87+0.5x1.52+0.1x1.62+0.2x1.43-0.4x1.40-0.3x1.37-0.9x
Debt-to-Equity0.48+0.2x0.330.0x0.350.0x0.330.0x0.320.0x0.310.0x0.310.0x0.32-0.1x
Asset Turnover0.070.0x0.070.0x0.080.0x0.080.0x0.070.0x0.070.0x0.080.0x0.070.0x
FCF Margin20.2%+1.8pp18.2%-0.1pp25.5%+2.5pp22.6%+1.7pp18.4%-1.3pp18.4%-6.6pp23.0%+4.5pp21.0%-2.5pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Danaher Corporation DHR FY2025 $24.6B $3.6B 14.7% $140.7B 60/100
Thermo Fisher Scientific Inc. TMO FY2025 $44.6B $6.7B 15.1% $223.0B 58/100
IDEXX Laboratories IDXX FY2025 $4.3B $1.1B 24.6% $39.9B 76/100
Agilent Technologies Inc A FY2025 $6.9B $1.3B 18.8% $40.8B 67/100
Mettler-Toledo MTD FY2025 $4.0B $869.2M 21.6% $25.7B 27/100
Labcorp Holdings Inc LH FY2025 $14.0B $877.0M 6.3% $24.9B 51/100

Frequently Asked Questions

What is Danaher Corporation's annual revenue?

Danaher Corporation (DHR) reported $24.6B in total revenue for fiscal year 2025. This represents a 2.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Danaher Corporation's revenue growing?

Danaher Corporation (DHR) revenue grew by 2.9% year-over-year, from $23.9B to $24.6B in fiscal year 2025.

Is Danaher Corporation profitable?

Yes, Danaher Corporation (DHR) reported a net income of $3.6B in fiscal year 2025, with a net profit margin of 14.7%.

Danaher Corporation (DHR) reported diluted earnings per share of $5.05 for fiscal year 2025. This represents a -4.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Danaher Corporation (DHR) had EBITDA of $7.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Danaher Corporation (DHR) had $4.6B in cash and equivalents against $18.4B in long-term debt.

Danaher Corporation (DHR) had a gross margin of 59.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Danaher Corporation (DHR) had an operating margin of 19.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Danaher Corporation (DHR) had a net profit margin of 14.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Danaher Corporation (DHR) has a return on equity of 6.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Danaher Corporation (DHR) generated $5.3B in free cash flow during fiscal year 2025. This represents a -0.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Danaher Corporation (DHR) generated $6.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Danaher Corporation (DHR) had $83.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Danaher Corporation (DHR) invested $1.2B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Danaher Corporation (DHR) invested $1.6B in research and development during fiscal year 2025.

Yes, Danaher Corporation (DHR) spent $3.1B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Danaher Corporation (DHR) had 707M shares outstanding as of fiscal year 2025.

Danaher Corporation (DHR) had a current ratio of 1.87 as of fiscal year 2025, which is generally considered healthy.

Danaher Corporation (DHR) had a debt-to-equity ratio of 0.35 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Danaher Corporation (DHR) had a return on assets of 4.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Danaher Corporation (DHR) trades at 35.1x earnings, its market capitalization divided by net income of $4.0B net income, trailing 12 months to June 26, 2026. The market capitalization is $140.7B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Danaher Corporation (DHR) trades at 5.6x sales, its market capitalization divided by revenue of $25.1B revenue, trailing 12 months to June 26, 2026. The market capitalization is $140.7B as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Danaher Corporation (DHR) has an Altman Z-Score of 4.08, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Danaher Corporation (DHR) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Danaher Corporation (DHR) has an earnings quality ratio of 1.78x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Danaher Corporation (DHR) has an interest coverage ratio of 17.70x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Danaher Corporation (DHR) scores 60 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top